ARATANA THERAPEUTICS
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.
ARATANA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Leawood, Kansas, United States
Country:
United States
Website Url:
http://www.aratana.com
Total Employee:
51+
Status:
Active
Contact:
913-951-2130
Total Funding:
128.51 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Google Google Maps API Google Cloud Amazon Virginia Region Microsoft GoDaddy
Similar Organizations
7 Hills Pharma
7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bactolife
Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance.
C2Sense
C2Sense, an MIT Engine โTough Techโ portfolio company, develops advanced sensing solutions for a healthier and safer world
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EVERSANA
EVERSANA is the provider of global services to the life science industry.
GelSana Therapeutics
GelSana Therapeutics develops new products to heal wounds faster.
Generian Pharmaceuticals
Generian has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks.
Gmax Biopharm
Gmax Biopharm dvelope innovative GPCR Antibody therapeutics for unmet medical use.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Journey Colab
Journey Colab pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities.
Korres
Their goal is to develop innovative and effective products based on natural, active ingredients.
VYNE Therapeutics
VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.
Nutrinia
Nutrinia is developing unique therapies for Intestinal failure patients.
PetSensus
A pet health ecosystem designed for happier, healthier, longer-living pets
Pharmaron
Pharmaron is a research and development service provider for the pharmaceutical industry.
Phyla
Phyla is developing alternative therapies for antibiotics.
Radius Health
Radius Health develops drug therapies for osteoporosis and womenโs health.
Sante Basque Developpement
Sante Basque Developpement is owns and operates mental health hospitals.
Tellus Therapeutics
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-01-06 | Okapi Sciences | Okapi Sciences acquired by Aratana Therapeutics | N/A |
2013-10-14 | Vet Therapeutics | Vet Therapeutics acquired by Aratana Therapeutics | N/A |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Aratana Therapeutics
Square 1 Bank
Square 1 Bank investment in Post-IPO Debt - Aratana Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Aratana Therapeutics
Women's Capital Connection
Women's Capital Connection investment in Series C - Aratana Therapeutics
Irv Hockaday
Irv Hockaday investment in Series C - Aratana Therapeutics
Midwest Venture Alliance
Midwest Venture Alliance investment in Series C - Aratana Therapeutics
Kauffman Foundation
Kauffman Foundation investment in Series C - Aratana Therapeutics
Mid-America Angels
Mid-America Angels investment in Series C - Aratana Therapeutics
Middleland Capital
Middleland Capital investment in Series C - Aratana Therapeutics
MPM Capital
MPM Capital investment in Series C - Aratana Therapeutics
More informations about "Aratana Therapeutics" on Search Engine
Elanco Finalizes Acquisition of Aratana Therapeutics
Jul 18, 2019 Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company โฆSee details»
Elanco Announces Agreement to Acquire Aratana โฆ
Apr 26, 2019 Aratana Therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. Aratana Therapeuticsโ โฆSee details»
Aratana Therapeutics Inc. | LinkedIn
Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. View all 16 employees. About us. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics โฆSee details»
Aratana Therapeutics Company Profile - Craft
Jun 7, 2019 Aratana Therapeutics is a pet therapeutics company focused on licensing, developing, and commercializing innovative therapeutics for dogs and cats. Its goal is to โฆSee details»
Elanco Finalizes Acquisition of Aratana Therapeutics
Jul 18, 2019 GREENFIELD, Ind.-- ( BUSINESS WIRE )--Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics โฆSee details»
Aratana Therapeutics to be Acquired by Elanco Animal โฆ
LEAWOOD, Kan., April 26, 2019 /PRNewswire/ -- Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative โฆSee details»
Elanco Animal Health to acquire Aratana Therapeutics
April 30, 2019. Elanco Animal Health has signed an agreement to acquire Aratana Therapeutics. The deal allows Elanco to integrate the Aratana portfolio of pet therapeutics into its companion animal therapeutics โฆSee details»
Aratana Therapeutics' Stockholders Adopt Merger โฆ
Jul 16, 2019 Aratana Therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. Our mission is to โฆSee details»
Aratana Therapeutics - InvestorRoom - Investor Overview
Corporate Headquarters. Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood, Kansas 66211See details»
Elanco Animal Health to acquire Aratana Therapeutics - dvm360
Apr 27, 2019 Since its founding in 2010, Kansas-based Aratana Therapeutics has become a major player in the animal health industry. Elanco Animal Health, a subsidiary โฆSee details»
Aratana Therapeutics: Update On The Rollout Of Galliprant And โฆ
Apr 19, 2017 2.07K Follower s. Summary. Galliprant is off to a fast start and the feedback from veterinarians has been positive; continuing to drive uptake and managing the โฆSee details»
Elanco Announces Agreement to Acquire Aratana Therapeutics; โฆ
Apr 26, 2019 GREENFIELD, Ind.-- ( BUSINESS WIRE )--Elanco Animal Health (NYSE:ELAN) today announced it has signed an agreement to acquire Aratana โฆSee details»
Aratana Therapeutics Appoints Co-Founder and Director Steven โฆ
Sep 14, 2012 KANSAS CITY, Kan. and NEW YORK, Sept. 12, 2012 -- Aratana Therapeutics, an animal health company developing innovative medicines for โฆSee details»
Aratana Enters Animal Health Industry With $20 Million In Funding
Jan 7, 2011 Aratana Therapeutics of Kansas City, Kan., reported today that it has received $20 million in Series A financing, led by MPM Capital and Avalon Ventures. The โฆSee details»
Aratana Therapeutics Expands Therapeutic Candidate Pipeline
Mar 1, 2018 Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. As a pioneer โฆSee details»
Aratana Therapeutics - InvestorRoom - Investor Presentations
Investor Presentations. The following slide presentations reflect information that is accurate only as of the date they were presented and are included here for background and โฆSee details»
Aratana Therapeutics - Finpedia
Dec 9, 2019 Aratana Therapeutics, Inc. (PETX) is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. As โฆSee details»
Aratana Therapeutics: What Does It Have In Store For The โฆ
Dec 8, 2017 What does Aratana Threapeutics (NASDAQ:PETX) do? Aratana Therapeutics, a US based pet therapeutics company, formed in 2010, belonging to the โฆSee details»